{
    "id": "5be94b87133db5eb78000020",
    "question": "Can gene therapy restore auditory function?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to analyze the provided documents and look for information related to gene therapy and its application in restoring auditory function. Gene therapy involves the introduction of a gene into cells to replace or repair a faulty gene. In the context of auditory function, gene therapy has been explored for various conditions that affect the auditory system. From Document [12], we know that gene therapy can be used to treat malignant diseases, including tumors, by directly injecting the gene into the tumor. However, the application of gene therapy to restore auditory function is a different context. From Document [13], we learn that stem cells play a crucial role in the auditory system, and research is being conducted to generate and manipulate stem cells artificially to improve auditory function. Document [14] discusses the use of gene therapy to treat inherited retinal degenerative disorders, such as Leber's congenital amaurosis, which affects the retina and causes blindness. Although this is a different condition, it shows that gene therapy can be effective in restoring function in specific contexts. From Document [30], we see that gene transfer has been successful in restoring visual function in patients with certain inherited retinal degenerative disorders. However, the question is whether gene therapy can restore auditory function. While there is no direct mention of gene therapy being used to restore auditory function in the provided documents, we can infer that gene therapy may be a promising approach for treating conditions that affect the auditory system. From Document [16], we know that tinnitus can be treated with gene therapy, which suggests that gene therapy may have a role in addressing auditory-related issues. However, the documents do not provide conclusive evidence that gene therapy can restore auditory function. Therefore, the most accurate answer is that gene therapy may not be able to restore auditory function, but it may be explored as a potential treatment for specific conditions affecting the auditory system.\", \"answer_choice\": \"B\"}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_2520",
            "title": "InternalMed_Harrison",
            "content": "PART 2 Cardinal Manifestations and Presentation of Diseases population are homozygous and affected. The hearing loss can also vary among the members of the same family, suggesting that other genes or factors influence the auditory phenotype. In addition to GJB2, several other nonsyndromic genes are associated with hearing loss that progresses with age. The contribution of genetics to presbycusis is also becoming better understood. Sensitivity to aminoglycoside ototoxicity can be maternally transmitted through a mitochondrial mutation. Susceptibility to noise-induced hearing loss may also be genetically determined."
        },
        {
            "id": "Pediatrics_Nelson_212",
            "title": "Pediatrics_Nelson",
            "content": "designed to substitute for the function of the middle ear,cochlear mechanical motion, and sensory cells, transformingsound energy into electrical energy that initiates impulses inthe auditory nerve. Cochlear implants are indicated for children older than 12 months with profound bilateral sensorineural hearing loss who have limited benefit from hearing aids,have failed to progress in auditory skill development, and haveno radiologic or medical contraindications. Implantation inchildren as young as possible gives them the most advantageous auditory environment for speech-language learning."
        },
        {
            "id": "Cell_Biology_Alberts_6164",
            "title": "Cell_Biology_Alberts",
            "content": "In contrast, in mammals at least, the auditory epithelium and the retinal epithelium lack stem cells, and their sensory receptor cells\u2014the sensory hair cells in the ear, the photoreceptors in the retina\u2014are irreplaceable. If they are destroyed\u2014 whether by too much exposure to loud noise, by looking into the beam of a laser, or through degenerative processes in old age\u2014the loss is permanent."
        },
        {
            "id": "Neurology_Adams_2252",
            "title": "Neurology_Adams",
            "content": "and causes of the two are quite different and that it is more practical to think of them as cochlear (end organ) and retrocochlear (nerve) deafness. (3) Central deafness, caused by lesions of the cochlear nuclei and their connections with the primary auditory receptive areas in the temporal lobes. For example, complete tone deafness, which is probably inherited as an autosomal dominant trait, is a central disorder."
        },
        {
            "id": "Histology_Ross_4356",
            "title": "Histology_Ross",
            "content": "A mutation that disrupts the gene that produces espin causes cochlear and vestibular symptoms in experimental mice. They lose their hearing early in life; these animals also spend most of their time walking or spinning in circles. The stereocilia of these animals do not maintain the rigidity necessary for proper functioning of the MET channels. All hair cells use mechanically gated ion channels to generate action potentials. All hair cells of the internal ear appear to function by moving (pivoting) their rigid stereocilia. Mechanoelectric transduction"
        },
        {
            "id": "Pediatrics_Nelson_211",
            "title": "Pediatrics_Nelson",
            "content": "The treatment of conductive hearing loss (largely due tootitis media and middle ear effusions) is discussed in Chapter 105. Treatment of sensorineural hearing impairment may bemedical or surgical. If amplification is indicated, hearing aidscan be tuned preferentially to amplify the frequency ranges inwhich the patient has decreased acuity. Educational intervention typically includes speech-language therapy and teachingAmerican Sign Language. Even with amplification, many hear-ing-impaired children show deficits in processing auditoryinformation, requiring special educational services for helpingto read and for other academic skills. Cochlear implants are surgically implantable devices that provide hearing sensation toindividuals with severe to profound hearing loss. The implantsare designed to substitute for the function of the middle ear,cochlear mechanical motion, and sensory cells, transformingsound energy into electrical energy that initiates impulses inthe auditory nerve."
        },
        {
            "id": "InternalMed_Harrison_2552",
            "title": "InternalMed_Harrison",
            "content": "In the event that the hearing aid provides inadequate rehabilitation, cochlear implants may be appropriate (Fig. 43-4). Criteria for implantation include severe to profound hearing loss with open-set sentence cognition of \u226440% under best aided conditions. Worldwide, more than 300,000 hearing-impaired individuals have received cochlear implants. Cochlear implants are neural prostheses that convert sound energy to electrical energy and can be used to stimulate the auditory division of the eighth nerve directly. In most cases of profound hearing impairment, the auditory hair cells are lost but the ganglionic cells of the auditory division of the eighth nerve are preserved. Cochlear implants consist of electrodes that are inserted into the cochlea through the round window, speech processors that extract acoustical elements of speech for conversion to electrical currents, and a means of transmitting the electrical energy through the skin. Patients with implants experience sound that helps"
        },
        {
            "id": "InternalMed_Harrison_2555",
            "title": "InternalMed_Harrison",
            "content": "The U.S. Food and Drug Administration recently approved the first hybrid cochlear implant for the treatment of high-frequency hearing loss. Patients with presbyacusis typically have normal low-frequency hearing, while suffering from high-frequency hearing loss associated with loss of clarity that cannot always be adequately rehabilitated with a hearing aid. However, these patients are not candidates for conventional cochlear implants because they have too much residual hearing. The hybrid implant has been specifically designed for this patient population; it has a shorter electrode than a conventional cochlear implant and can be introduced into the cochlea atraumatically, thus preserving low-frequency hearing. Individuals with a hybrid implant use their own natural low-frequency \u201cacoustic\u201d hearing and rely on the implant for providing \u201celectrical\u201d high-frequency hearing. Patients who have received the hybrid implant perform better on speech testing in both quiet and noisy backgrounds."
        },
        {
            "id": "InternalMed_Harrison_2550",
            "title": "InternalMed_Harrison",
            "content": "hearing aid in that the patient wears a hearing aid, and not simply a receiver, in the better ear. Unfortunately, while CROS and BAHA devices provide benefit, they do not restore hearing in the deaf ear. Only cochlear implants can restore hearing (see below). Increasingly, cochlear implants are being investigated for the treatment of patients with single-sided deafness; early reports show great promise in not only restoring hearing but also improving sound localization and performance in background noise."
        },
        {
            "id": "Neurology_Adams_8972",
            "title": "Neurology_Adams",
            "content": "Chap. 34. The later onset and progressive nature of deafness in this and several other syndromes are distinguished from forms of congenital deafness that are typical of the group discussed below. Hereditary Hearing Loss With Diseases of the Nervous System (See Table 14-1)"
        },
        {
            "id": "Pediatrics_Nelson_206",
            "title": "Pediatrics_Nelson",
            "content": "antibiotics), and tumors and their treatments. Genetic deafness may be either dominant or recessive in inheritance; this is the main cause of hearing impairment in schools for the deaf. In Down syndrome, there is a predisposition to conductive loss caused by middle ear infection"
        },
        {
            "id": "Neurology_Adams_2302",
            "title": "Neurology_Adams",
            "content": "other main hereditary syndromes. Chinnery et al have summarized the mitochondrial causes of deafness. Chapters 37 and 39 discuss further the association of neurosensory deafness with degenerative and developmental neurologic disease."
        },
        {
            "id": "Surgery_Schwartz_3351",
            "title": "Surgery_Schwartz",
            "content": "of interest. In most gene therapy trials for malignant diseases, tumors can be accessed and directly injected (in situ gene therapy). In situ gene therapy also offers a better distribution of the vector virus throughout the tumor. Finally, a combination of gene therapy strategies will be more effective than the use of a single gene therapy system. An important aspect of effective gene therapy involves the choice of appropriate genes for manipulation. Genes that promote the production of messenger chemicals or other immune-active sub-stances can be transferred into the patient\u2019s cells. These include genes that inhibit cell cycle progression, induce apoptosis, enhance host immunity against cancer cells, block the ability of cancer cells to metastasize, and cause tumor cells to undergo suicide. Recent development of RNAi technology, which uses a loss-of-function approach to block gene functions, ensures a new wave of hopes for gene therapy. Nonetheless, gene therapy is still experimental"
        },
        {
            "id": "Cell_Biology_Alberts_6112",
            "title": "Cell_Biology_Alberts",
            "content": "We shall examine in particular the role played in many tissues by stem cells\u2014 cells that are specialized to provide a fresh supply of differentiated cells where these need to be continually replaced, or when they are required in great number for purposes of repair and regeneration. We shall see that while many tissues renew and repair themselves, some others do not; there, lost cells are lost forever, causing deafness, blindness, dementia, and other ills. In the final section of the chapter, we discuss how stem cells can be generated and manipulated artificially, and we confront the practical question that underlies the current storm of interest in stem-cell technology: How can we use our understanding of the processes of cell differentiation and tissue renewal to improve upon nature, and make good those injuries and failings of the human body that have hitherto seemed to be beyond repair?"
        },
        {
            "id": "InternalMed_Harrison_2506",
            "title": "InternalMed_Harrison",
            "content": "Sensorineural Hearing Loss Sensorineural hearing loss results from either damage to the mechanotransduction apparatus of the cochlea or disruption of the electrical conduction pathway from the inner ear to the brain. Thus, injury to hair cells, supporting cells, auditory neurons, or the central auditory pathway can cause sensorineural hearing loss. Damage to the hair cells of the organ of Corti may be caused by intense noise, viral infections, ototoxic drugs (e.g., salicylates, quinine and its synthetic analogues, aminoglycoside antibiotics, loop diuretics such as furosemide and ethacrynic acid, and cancer chemotherapeutic agents such as cisplatin), fractures of the temporal bone, meningitis, cochlear otosclerosis (see above), M\u00e9ni\u00e8re\u2019s disease, and aging. Congenital malformations of the inner ear may be the cause of hearing loss in some adults. Genetic predisposition alone or in concert with environmental exposures may also be responsible (see below)."
        },
        {
            "id": "Neurology_Adams_4639",
            "title": "Neurology_Adams",
            "content": "Speech delay caused by congenital deafness, whether peripheral (loss of pure-tone acuity) or central (pure-tone threshold normal by audiogram), is a most important condition but may at first be difficult to discern. One suspects that faulty hearing is causal when there is a history of familial deaf mutism, congenital rubella, erythroblastosis fetalis, meningitis, chronic bilateral ear infections, or the administration of ototoxic drugs to the pregnant mother or newborn infant\u2014the well-known antecedents of deafness. It is estimated that approximately 3 million American children have hearing defects; 0.1 percent of the school population are deaf and 1.5 percent are hard of hearing. The parents\u2019 attention may be drawn to a defect in hearing when the infant fails to heed loud noises, to turn the eyes to sound sources outside the immediate visual fields, and to react to music; but in other instances, it is the delay in speaking that calls attention to it."
        },
        {
            "id": "InternalMed_Harrison_2556",
            "title": "InternalMed_Harrison",
            "content": "For individuals who have had both eighth nerves destroyed by trauma or bilateral vestibular schwannomas (e.g., neurofibromatosis type 2), brainstem auditory implants placed near the cochlear nucleus may provide auditory rehabilitation. Tinnitus often accompanies hearing loss. As for background noise, tinnitus can degrade speech comprehension in individuals with hearing impairment. Therapy for tinnitus is usually directed toward minimizing the appreciation of tinnitus. Relief of the tinnitus may be obtained by masking it with background music. Hearing aids are also helpful in tinnitus suppression, as are tinnitus maskers, devices that present a sound to the affected ear that is more pleasant to listen to than the tinnitus. The use of a tinnitus masker is often followed by several hours of inhibition of the tinnitus. Antidepressants have been shown to be beneficial in helping patients cope with tinnitus."
        },
        {
            "id": "InternalMed_Harrison_2508",
            "title": "InternalMed_Harrison",
            "content": "amplification with hearing aids may provide only limited rehabilitation once the word recognition score deteriorates below 50%. Cochlear implants are the treatment of choice when hearing aids prove inadequate, even when hearing loss is incomplete (see below)."
        },
        {
            "id": "Neurology_Adams_2298",
            "title": "Neurology_Adams",
            "content": "The singular genetic advance in this field has been the identification in recessive nonsyndromic deafness of a mutation of the connexin-26 gene on chromosome 13 (designated GJB2). This mutation is found in half of recessive familial cases of pure deafness; what is more striking is that the same gene abnormality occurs in 37 percent of cases of sporadic congenital deafness, almost certainly from a spontaneous mutation (Estivill et al and Morell et al). The connexin protein is a component of gap junctions and the mutation is theorized to interfere with the recycling of potassium from the cochlear hair cells to the endolymph. As a result of the human genome project, more than 20 other gene loci have been detected that may be related to congenital deafness syndromes; these have been summarized by Tekin and colleagues, but none, except the one for connexin, accounts for more than a very small proportion of cases. These unattached, nonsyndromic types of congenital deafness are denominated"
        },
        {
            "id": "Physiology_Levy_1189",
            "title": "Physiology_Levy",
            "content": "Fig. 10.10 ), and restoration of normal visual input after the critical period does not undo the abnormality, nor does it restore functional vision from the deprived eye. In contrast, similar visual deprivation later in life does not result in abnormal connections. The plastic changes seen in such experiments may reflect a competition for synaptic connections, whereby the less functional connections are pruned away. Research has shown a correlation between the form of a gene that modulates the efficacy of synaptic pruning and the probability of schizophrenia."
        },
        {
            "id": "Neurology_Adams_2407",
            "title": "Neurology_Adams",
            "content": "N Engl J Med 310:1700, 1984. Jeong SH, Choi SH, Kim JY, et al. Osteopenia and osteoporosis in idiopathic benign positional vertigo. Neurology 24:1069\u20131076. 2009. Kasai K, Asada T, Yumoto M, et al: Evidence for functional abnormality in the right auditory cortex during musical hallucinosis. Lancet 354:1703, 1999. Konigsmark BW: Hereditary deafness in man. N Engl J Med 281:713, 774, 827, 1969. Konigsmark BW: Hereditary diseases of the nervous system with hearing loss. In: Vinken PJ, Bruyn GW (eds): Handbook of Clinical Neurology. Vol 22. Amsterdam, North-Holland, 1975, pp 499\u2013526. Kroenke K, Mangelsdorff AD: Common symptoms in ambulatory care: Incidence, evaluation, therapy, and outcome. Am J Med 86:262, 1989. Lockwood AH, Salvi RJ, Burkard RF: Tinnitus. N Engl J Med 347:904, 2002. Marion MS, Cevette MJ: Tinnitus. Mayo Clin Proc 66:614, 1991. Mattox DE, Simmons FB: Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 86:463, 1977."
        },
        {
            "id": "Histology_Ross_4342",
            "title": "Histology_Ross",
            "content": "\u0081 FOLDER 25.2 Clinical Correlation: Hearing Loss\u2014Vestibular Dysfunction"
        },
        {
            "id": "InternalMed_Harrison_2530",
            "title": "InternalMed_Harrison",
            "content": "LABORATORY ASSESSMENT OF HEARINg Audiologic Assessment The minimum audiologic assessment for hearing loss should include the measurement of pure tone air-conduction and bone-conduction thresholds, speech reception threshold, word recognition score, tympanometry, acoustic reflexes, and acoustic-reflex decay. This test battery provides a screening evaluation of the entire auditory system and allows one to determine whether further PART 2 Cardinal Manifestations and Presentation of Diseases Abbreviations: BOR, branchio-oto-renal syndrome; WS, Waardenburg\u2019s syndrome. differentiation of a sensory (cochlear) from a neural (retrocochlear) hearing loss is indicated."
        },
        {
            "id": "InternalMed_Harrison_2554",
            "title": "InternalMed_Harrison",
            "content": "CHAPTER 43 Disorders of Hearing PART 2 Cardinal Manifestations and Presentation of Diseases FIguRE 43-4 A cochlear implant is composed of an external microphone and speech processor worn on the ear and a receiver implanted underneath the temporalis muscle. The internal receiver is attached to an electrode that is placed surgically in the cochlea."
        },
        {
            "id": "Neurology_Adams_4628",
            "title": "Neurology_Adams",
            "content": "(cochlear and eighth nerve) abnormalities in the infant and young child. After the first few months, impaired hearing becomes more obvious and interferes with language development, as described in the following text. It is of interest that the identification and remediation of early (infants) hearing defects by screening leads to higher scores on language tests later in childhood but not improved speech, according to a study by Kennedy and colleagues."
        },
        {
            "id": "Neurology_Adams_8956",
            "title": "Neurology_Adams",
            "content": "This mitochondrial disease should not be mistaken for Leber\u2019s congenital amaurosis, a retinal degeneration with a mutation in RPE65 that affects photoreceptors and causes infantile blindness. The latter disease assumes importance in part because it has an established gene therapy with some efficacy."
        },
        {
            "id": "Neurology_Adams_2277",
            "title": "Neurology_Adams",
            "content": "a hearing aid that improves audition may suppress or diminish tinnitus. Antiepileptic drugs and tocainide hydrochloride have been suggested as treatments, but have not been helpful in our experience. Some success in reducing the symptom has been achieved with small doses of amitriptyline at night. In extreme circumstances some groups have experimented with implanted stimulators on the temporal cortex."
        },
        {
            "id": "Neurology_Adams_2475",
            "title": "Neurology_Adams",
            "content": "Auditory hallucinations are infrequent as an initial manifestation of a seizure and usually represent a psychotic disorder or one of several more benign conditions. Occasionally, a patient with a focus in one superior temporal convolution will report a buzzing or roaring in the ears. A human voice, sometimes repeating unrecognizable words, or the sound of music has been noted a few times with lesions in the more posterior part of one temporal lobe. Some people with epilepsy and a strong family history of seizures with auditory auras, may have normal imaging but turn out to have mutations in the LGI1 gene."
        },
        {
            "id": "Neurology_Adams_2297",
            "title": "Neurology_Adams",
            "content": "A large number of genetically determined syndromes that feature a neural or conductive type of deafness\u2014some congenital and others having their onset in childhood or early adult life\u2014have come to light (see articles by Tekin et al and Gorlin et al). The majority of cases of congenital deafness are inherited as an autosomal recessive trait with no other syndromic features. In most of the remainder, inheritance is autosomal dominant in type and in a small number, it is sex linked."
        },
        {
            "id": "InternalMed_Harrison_2517",
            "title": "InternalMed_Harrison",
            "content": "More than half of childhood hearing impairment is thought to be hereditary; hereditary hearing impairment (HHI) can also manifest later in life. HHI may be classified as either nonsyndromic, when hearing loss is the only clinical abnormality, or syndromic, when hearing loss is associated with anomalies in other organ systems. Nearly two-thirds of HHIs are nonsyndromic, and the remaining one-third are syndromic. Between 70 and 80% of nonsyndromic HHI is inherited in an autosomal recessive manner and designated DFNB; another 15\u201320% is autosomal dominant (DFNA). Less than 5% is X-linked (DFNX) or maternally inherited via the mitochondria."
        },
        {
            "id": "InternalMed_Harrison_5431",
            "title": "InternalMed_Harrison",
            "content": "to be stable, with the first animals treated >10 years ago continuing to manifest electroretinal and behavioral evidence of visual function. As is the case for X-linked SCID, gene transfer must occur relatively early in life to achieve optimal correction of the genetic disease, although the exact limitations imposed by age have not yet been defined. AAV-RPE65 trials carried out in both the United States and the United Kingdom have shown restoration of visual and retinal function in over 30 subjects, with the most marked improvement occurring in the younger subjects. Trials for other inherited retinal degenerative disorders such as choroideremia are under way, as are studies for certain complex acquired disorders such as age-related macular degeneration, which affects several million people worldwide. The neovascularization that occurs in age-related macular degeneration can be inhibited by expression of vascular endothelial growth factor (VEGF) inhibitors such as angiostatin or"
        },
        {
            "id": "InternalMed_Harrison_5422",
            "title": "InternalMed_Harrison",
            "content": "after affected siblings had begun to lose milestones. These results illustrate that the ability to engineer levels of expression can allow gene therapy approaches to succeed where allogeneic bone marrow transplantation cannot. It is likely that a similar approach will be used in other neurodegenerative conditions."
        }
    ],
    "scores": [
        0.03339909440478701,
        0.02981289910099221,
        0.029128044048089736,
        0.02648679411581813,
        0.02514262287542026,
        0.024954212454212456,
        0.02470534728808577,
        0.02445210713207862,
        0.02443194023125809,
        0.02355261439929632,
        0.02337556637019634,
        0.02310676965015902,
        0.022950486065240167,
        0.022095171557211614,
        0.02142717395101841,
        0.02056242705523336,
        0.02025804262962841,
        0.020239421870927254,
        0.020203612293238842,
        0.01998588968236132,
        0.019911647603370896,
        0.0177750058470414,
        0.01774915573706118,
        0.017645245800585605,
        0.01731893837156995,
        0.017185900248647065,
        0.016443850267379677,
        0.016385916857119907,
        0.016335978835978836,
        0.016203703703703703,
        0.016174948240165632,
        0.015574650912996778
    ]
}